Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Optic Glioma at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Optic Glioma Session

An optic glioma is a specialized tumor that develops along the optic nerve, linking the eye to the brain. These tumors, though typically slow-growing, predominantly affect children. They manifest through vision impairment, such as reduced visual acuity, peripheral vision loss, and in severe cases, blindness. Additional symptoms may include irregular eye movements, headaches, and hormonal disturbances due to potential involvement of the nearby pituitary gland.

Diagnosis usually involves advanced imaging techniques like MRI or CT scans to precisely locate and assess the tumor's extent. Treatment approaches vary based on tumor characteristics and patient health, ranging from careful monitoring to surgical removal, radiation therapy, or chemotherapy. Continuous monitoring by ophthalmologists and other specialists remains crucial for effective management of optic gliomas and prevention of potential complications.

Topics Covered in Optic Glioma

Topic 01

Pilocytic Astrocytoma

Topic 02

Neurofibromatosis Type 1

Topic 03

Chiasmal-Hypothalamic Glioma

Topic 04

MRI Surveillance

Topic 05

Carboplatin & Vincristine

Topic 06

MEK Inhibitors

Related Scientific Sessions at IOC 2027

Why Attend the Optic Glioma Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Optic Glioma work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Optic Glioma research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Optic Glioma track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Optic Glioma Conference 2027 — FAQs

What is the Optic Glioma track at IOC 2027?

The Optic Glioma track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Optic Glioma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Optic Glioma sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Optic Glioma are all welcome — whether presenting or attending.

Can I present my research in the Optic Glioma track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Optic Glioma sessions?

Yes. IOC 2027 is a hybrid conference — attend the Optic Glioma track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us